The establishment of programs and research centers for elderly health is escalating the European Geriatric Medicine Market

Published: Nov 2020

The European geriatric medicine market is projected to grow at a CAGR of 5.4% during the forecast period (2020-2026). Geriatric medicine is fostering in Europe with the rising burden of healthcare disorders in elderly people. European Union Geriatric Medicine Society (EUgMS) is a journal that specifically focuses on geriatric medicine in Europe. Its scope includes a comprehensive analysis of all factors of geriatric medicine in the region, both with a clinical and academic focus. This involves setting up the functionality in old age, comprehensive geriatric assessment, geriatric syndromes, education, models of care in health services.

Browse the full report description European Geriatric Medicine Market Size, Share & Trends Analysis Report by Therapeutic (Analgesic, Anticoagulant, Antihypertensive, Antidiabetic, and Others) and by Condition (Cardiovascular Diseases (CVDs), Diabetes, Neurological, Cancer, Respiratory, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/europe-geriatric-medicine-market

European Academy for Medicine of Aging (EAMA) is an academic institute that focuses on improving the knowledge and skills in geriatric medicine among the upcoming healthcare providers and specialists. This further includes the discussion regarding the development of new ideas and programs for geriatric health and harmonize practices. Such a huge focus of the European economies towards the development of better healthcare infrastructure for the elderly population will drive the geriatric medicine market growth in the region during the forecast period. 

Market Coverage

Report Elements

Details

Study Period

2019-2026

Base year

2019

Forecast period

2020-2026

Segments Covered

By Therapeutics and By Condition

Countries Covered

UK, Germany, France, Italy, Spain, and Rest of Europe

Key Companies Profiled

Novartis AG, GlaxoSmithKline Plc, Sanofi SA, Boehringer Ingelheim GmbH, AstraZeneca PLC, and Pfizer Inc.

Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment/region dominates the market in the base year?
  • Which segment/region will project the fastest growth in the market during the forecast period?
  • How COVID-19 will impact the market growth in 2020 and coming years?

o Recovery Timeline

o Deviation from pre-COVID-19 

o Most affected region/segment

o Recommendations 

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

European Geriatric Medicine Market – Segmentation

By Therapeutics

  • Analgesic
  • Anticoagulant
  • Antihypertensive 
  • Antidiabetic
  • Others (Statins and Antipsychotic)

By Condition

  • Cardiovascular Diseases (CVDs)
  • Diabetes
  • Neurological
  • Cancer
  • Respiratory
  • Others (Arthritis and Osteoporosis) 

European Geriatric Medicine Market – Segmentation by Geography

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/europe-geriatric-medicine-market